News

Proteomics International showcased Promarker™ platform at HUPO 2019

Proteomics International attended the 18th Human Proteome Organization World Congress, September 15th – 19th in Adelaide, South Australia. HUPO 2019 is a point of contact for proteomics research and commercialisation activities worldwide, where cutting edge proteomics research is presented and discussed. Proteomics International is exhibiting from Booth #29.

Proteomics International also presented three scientific posters showcasing our biomarker discovery platform:
PromarkerD as an immunoaffinity mass spectrometry assay for diabetic kidney disease (#441)
Biomarkers of endometriosis (#591)
PromarkerD: A novel test for predicting rapid decline in renal function in type 2 diabetes (#660)

Media Release

Subscribe
  • This field is for validation purposes and should be left unchanged.